{"altmetric_id":14268299,"counts":{"readers":{"mendeley":26,"citeulike":0,"connotea":0},"total":{"posts_count":22},"twitter":{"unique_users_count":15,"unique_users":["ThromboAdviser","hemomad","tromboinfo","amartjim","Cihan_Ay_MD","CancerClot","emersons694","MaryCushmanMD","RPTHjournal","ThrombosisCan","thrombosisday","GFHT_Hemostase","isth","MarcBlondon","TH_Journal"],"posts_count":21},"facebook":{"unique_users_count":1,"unique_users":["1447144365538983"],"posts_count":1}},"selected_quotes":["Direct oral anticoagulants (#DOACs) offer a potentially promising treatment option for #cancer patients with #VTE","Be aware of #Cancer-associated #VTE on #WorldCancerDay: Burden, mechanisms and management @TH_Jour\u2026","Great article by #RPTH associate editor","Free Review by Ay et al. on epidemiology, pathophysiology and clinical treatment options of cancer-associated VTE","@CancerClot: Significant health problem in #cancer.Review article summarising the burden, mechanisms and management"],"citation":{"abstract":"Venous thromboembolism (VTE) is a significant health problem in the general population but especially in cancer patients. In this review, we discuss the epidemiology and burden of the disease, the pathophysiology of cancer-associated VTE, and the clinical treatment options for both primary prevention and acute treatment. Overall, the development of VTE in cancer patients is related to increases in morbidity, mortality, and medical costs. However, the incidence of cancer-associated VTE varies due to patient-related factors (e.g. thrombophilia, comorbidities, performance status, history of venous diseases), tumour-related factors (e.g. cancer site, stage, grade), and treatment-related factors (e.g. surgery, chemotherapy, anti-angiogenesis treatment, hormonal and supportive treatment). Furthermore, blood count parameters (e.g. platelets and leukocytes) and biomarkers (e.g. soluble P-selectin and D-dimer) are predictive markers for the risk of VTE in cancer patients and have been used to enhance risk stratification. Evidence suggests that cancer itself is associated with a state of hypercoagulability, driven in part by the release of procoagulant factors, such as tissue factor, from malignant tissue as well as by inflammation-driven activation of endothelial cells, platelets, and leukocytes. In general, low-molecular-weight heparin (LWMH) monotherapy is the standard of care for the management of cancer-associated VTE, as vitamin K antagonists are less effective in cancer patients. Direct oral anticoagulants (DOACs) offer a potentially promising treatment option for cancer patients with VTE, but recommendations concerning the routine use of DOACs should await head-to-head studies with LMWH.","altmetric_jid":"4f6fa63a3cf058f610008b6f","authors":["Schattauer GmbH - Publishers for Medicine and Natural Sciences","C. Ay","I. Pabinger","A. T. Cohen"],"doi":"10.1160\/th16-08-0615","first_seen_on":"2016-12-02T14:30:52+00:00","funders":["niehs"],"issns":["0340-6245"],"issue":"2","journal":"Thrombosis and Haemostasis","last_mentioned_on":1486566215,"links":["https:\/\/th.schattauer.de\/contents\/archive\/issue\/special\/manuscript\/26900.html?utm_content=buffer9ab74&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer","https:\/\/th.schattauer.de\/contents\/archive\/issue\/2446\/manuscript\/26900.html","https:\/\/doi.org\/10.1160\/TH16-08-0615"],"pdf_url":"\/\/www.schattauer.de\/index.php?id=5236&mid=26900","pmid":"27882374","pubdate":"2016-12-02T20:17:00+00:00","publisher":"Schattauer Publishers","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"},{"name":"Cardiovascular Medicine And Haematology","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["hematology"],"title":"Cancer-associated venous thromboembolism: Burden, mechanisms, and management","type":"article","uri":"http:\/\/www.schattauer.de\/index.php?id=1214&doi=10.1160\/TH16-08-0615","volume":"117","mendeley_url":"http:\/\/www.mendeley.com\/research\/cancerassociated-venous-thromboembolism-burden-mechanisms-management"},"altmetric_score":{"score":10.4,"score_history":{"1y":10.4,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":10.4},"context_for_score":{"all":{"total_number_of_other_articles":8204609,"mean":6.9463486089701,"rank":800837,"this_scored_higher_than_pct":90,"this_scored_higher_than":7402703,"rank_type":"exact","sample_size":8204609,"percentile":90},"similar_age_3m":{"total_number_of_other_articles":269942,"mean":12.055747863422,"rank":39925,"this_scored_higher_than_pct":85,"this_scored_higher_than":229942,"rank_type":"exact","sample_size":269942,"percentile":85},"this_journal":{"total_number_of_other_articles":868,"mean":3.4124705882353,"rank":37,"this_scored_higher_than_pct":95,"this_scored_higher_than":831,"rank_type":"exact","sample_size":868,"percentile":95},"similar_age_this_journal_3m":{"total_number_of_other_articles":76,"mean":2.6684,"rank":1,"this_scored_higher_than_pct":98,"this_scored_higher_than":75,"rank_type":"exact","sample_size":76,"percentile":98}}},"demographics":{"poster_types":{"member_of_the_public":11,"researcher":1,"science_communicator":3},"users":{"twitter":{"cohorts":{"Members of the public":11,"Scientists":1,"Science communicators (journalists, bloggers, editors)":3}},"mendeley":{"by_status":{"Unspecified":2,"Student  > Doctoral Student":2,"Researcher":1,"Student  > Ph. D. Student":7,"Student  > Postgraduate":2,"Student  > Master":5,"Other":2,"Student  > Bachelor":3,"Lecturer > Senior Lecturer":1,"Professor":1},"by_discipline":{"Medicine and Dentistry":14,"Immunology and Microbiology":2,"Agricultural and Biological Sciences":4,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":3,"Pharmacology, Toxicology and Pharmaceutical Science":2}}},"geo":{"twitter":{"ES":1,"AT":1,"DK":1,"IE":1,"US":2,"FR":1,"CH":1,"DE":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/ThromboAdviser\/statuses\/804694279188869121","license":"gnip","citation_ids":[14268299],"posted_on":"2016-12-02T14:30:41+00:00","author":{"name":"Thrombosis Adviser","url":"http:\/\/www.ThrombosisAdviser.com","image":"https:\/\/pbs.twimg.com\/profile_images\/811559526977728516\/OfjraTHP_normal.jpg","description":"Welcome to ThrombosisAdviser, an online resource for physicians and patients about current and emerging therapies for thromboembolic disease.","id_on_source":"ThromboAdviser","tweeter_id":"41365449","geo":{"lt":null,"ln":null},"followers":12395},"tweet_id":"804694279188869121"},{"url":"http:\/\/twitter.com\/hemomad\/statuses\/804696538232582144","license":"gnip","rt":["ThromboAdviser"],"citation_ids":[14268299],"posted_on":"2016-12-02T14:39:39+00:00","author":{"name":"Hemomadrid","url":"http:\/\/www.hemomadrid.com","image":"https:\/\/pbs.twimg.com\/profile_images\/677778850990989312\/9ipydFEh_normal.png","description":"Equipo de Hemat\u00f3logos. Consulta on line. Anticoagulaci\u00f3n. Transfusi\u00f3n. Fertilidad.\nhttps:\/\/www.facebook.com\/hemomadridsocial\/","id_on_source":"hemomad","tweeter_id":"2783864552","geo":{"lt":40.42526,"ln":-3.69063,"country":"ES"},"followers":394},"tweet_id":"804696538232582144"},{"url":"http:\/\/twitter.com\/tromboinfo\/statuses\/804733002077138945","license":"gnip","rt":["ThromboAdviser"],"citation_ids":[14268299],"posted_on":"2016-12-02T17:04:33+00:00","author":{"name":"trombo.info","url":"http:\/\/www.trombo.info","image":"https:\/\/pbs.twimg.com\/profile_images\/654056378164752384\/K1AbCB0v_normal.jpg","description":"Tu web sobre enfermedad tromboemb\u00f3lica venosa #ETV #trombosis #emboliapulmonar #RIETEregistry  Your site about venous thromboembolism #bloodclot #DVT #PE #VTE","id_on_source":"tromboinfo","tweeter_id":"2280734660","geo":{"lt":null,"ln":null},"followers":508},"tweet_id":"804733002077138945"},{"url":"http:\/\/twitter.com\/amartjim\/statuses\/805052702019518464","license":"gnip","rt":["ThromboAdviser"],"citation_ids":[14268299],"posted_on":"2016-12-03T14:14:55+00:00","author":{"name":"\u00c1ngel Mart\u00ednez","image":"https:\/\/pbs.twimg.com\/profile_images\/880125802469347328\/pzvEaAPD_normal.jpg","description":"Ingeniero aeroespacial y amante de la libertad, la astronom\u00eda y el basket. Colaborador en @Planetacb y cofundador de @pfelipesegundo","id_on_source":"amartjim","tweeter_id":"1867697336","geo":{"lt":null,"ln":null},"followers":2577},"tweet_id":"805052702019518464"},{"url":"http:\/\/twitter.com\/Cihan_Ay_MD\/statuses\/827813656553517056","license":"gnip","citation_ids":[14268299],"posted_on":"2017-02-04T09:38:50+00:00","author":{"name":"Cihan Ay","image":"https:\/\/pbs.twimg.com\/profile_images\/827814018660388864\/YHatyhrv_normal.jpg","id_on_source":"Cihan_Ay_MD","tweeter_id":"277967241","geo":{"lt":48.2082,"ln":16.37169,"country":"AT"},"followers":153},"tweet_id":"827813656553517056"},{"url":"http:\/\/twitter.com\/Cihan_Ay_MD\/statuses\/827817905618292737","license":"gnip","citation_ids":[14268299],"posted_on":"2017-02-04T09:55:43+00:00","author":{"name":"Cihan Ay","image":"https:\/\/pbs.twimg.com\/profile_images\/827814018660388864\/YHatyhrv_normal.jpg","id_on_source":"Cihan_Ay_MD","tweeter_id":"277967241","geo":{"lt":48.2082,"ln":16.37169,"country":"AT"},"followers":153},"tweet_id":"827817905618292737"},{"url":"http:\/\/twitter.com\/CancerClot\/statuses\/827825185470443520","license":"gnip","rt":["Cihan_Ay_MD"],"citation_ids":[14268299],"posted_on":"2017-02-04T10:24:39+00:00","author":{"name":"CancerClot","url":"http:\/\/leo-pharma.com","image":"https:\/\/pbs.twimg.com\/profile_images\/725229444554735618\/oIHQusd-_normal.jpg","description":"LEO Pharma Global Twitter feed on #bloodclot (#thrombosis) related issues with focus on #cancer. Read our Social Media principles here http:\/\/bit.ly\/2939tlK","id_on_source":"CancerClot","tweeter_id":"717253294138212353","geo":{"lt":56,"ln":10,"country":"DK"},"followers":1099},"tweet_id":"827825185470443520"},{"url":"http:\/\/twitter.com\/emersons694\/statuses\/827845845949227008","license":"gnip","rt":["Cihan_Ay_MD"],"citation_ids":[14268299],"posted_on":"2017-02-04T11:46:44+00:00","author":{"name":"Fionnuala N\u00ed \u00c1inle","image":"https:\/\/pbs.twimg.com\/profile_images\/866246729640837121\/HfAKT8hx_normal.jpg","description":"Haematologist, passionate about thrombosis prevention and treatment. Views my own, RT not endorsement","id_on_source":"emersons694","tweeter_id":"2541766642","geo":{"lt":53.33306,"ln":-6.24889,"country":"IE"},"followers":315},"tweet_id":"827845845949227008"},{"url":"http:\/\/twitter.com\/MaryCushmanMD\/statuses\/827886149054111744","license":"gnip","rt":["Cihan_Ay_MD"],"citation_ids":[14268299],"posted_on":"2017-02-04T14:26:53+00:00","author":{"name":"Mary Cushman MD","url":"http:\/\/www.UVMHealth.org\/MedCenterTHP","image":"https:\/\/pbs.twimg.com\/profile_images\/579692709775962112\/FKn2-GLd_normal.jpg","description":"Director, Thrombosis & Hemostasis Program, U of Vermont Med Center. Professor of Medicine, Larner College of Medicine, UVM. Editor, @RPTHJournal Tweets r my own","id_on_source":"MaryCushmanMD","tweeter_id":"3104963032","geo":{"lt":44.47588,"ln":-73.21207,"country":"US"},"followers":775},"tweet_id":"827886149054111744"},{"url":"http:\/\/twitter.com\/MaryCushmanMD\/statuses\/827886447214596096","license":"gnip","citation_ids":[14268299],"posted_on":"2017-02-04T14:28:05+00:00","author":{"name":"Mary Cushman MD","url":"http:\/\/www.UVMHealth.org\/MedCenterTHP","image":"https:\/\/pbs.twimg.com\/profile_images\/579692709775962112\/FKn2-GLd_normal.jpg","description":"Director, Thrombosis & Hemostasis Program, U of Vermont Med Center. Professor of Medicine, Larner College of Medicine, UVM. Editor, @RPTHJournal Tweets r my own","id_on_source":"MaryCushmanMD","tweeter_id":"3104963032","geo":{"lt":44.47588,"ln":-73.21207,"country":"US"},"followers":775},"tweet_id":"827886447214596096"},{"url":"http:\/\/twitter.com\/RPTHjournal\/statuses\/827889361286987777","license":"gnip","citation_ids":[14268299],"posted_on":"2017-02-04T14:39:39+00:00","author":{"name":"RPTH","url":"http:\/\/onlinelibrary.wiley.com\/journal\/10.1002\/(ISSN)2475-0379","image":"https:\/\/pbs.twimg.com\/profile_images\/818561357838741504\/_r5xuKmG_normal.jpg","description":"Research & Practice in Thrombosis & Haemostasis (#RPTH) is the new peer-reviewed open access journal of the International Society on #Thrombosis & #Haemostasis","id_on_source":"RPTHjournal","tweeter_id":"798920671770382336","geo":{"lt":null,"ln":null},"followers":485},"tweet_id":"827889361286987777"},{"url":"http:\/\/twitter.com\/CancerClot\/statuses\/827894372964429826","license":"gnip","rt":["Cihan_Ay_MD"],"citation_ids":[14268299],"posted_on":"2017-02-04T14:59:34+00:00","author":{"name":"CancerClot","url":"http:\/\/leo-pharma.com","image":"https:\/\/pbs.twimg.com\/profile_images\/725229444554735618\/oIHQusd-_normal.jpg","description":"LEO Pharma Global Twitter feed on #bloodclot (#thrombosis) related issues with focus on #cancer. Read our Social Media principles here http:\/\/bit.ly\/2939tlK","id_on_source":"CancerClot","tweeter_id":"717253294138212353","geo":{"lt":56,"ln":10,"country":"DK"},"followers":1099},"tweet_id":"827894372964429826"},{"url":"http:\/\/twitter.com\/ThrombosisCan\/statuses\/827905943723765765","license":"gnip","rt":["Cihan_Ay_MD"],"citation_ids":[14268299],"posted_on":"2017-02-04T15:45:33+00:00","author":{"name":"Thrombosis Canada","url":"http:\/\/www.thrombosiscanada.ca","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000743360200\/db9638d6bf2a346390c0817999ecddd4_normal.jpeg","description":"Dedicated to Furthering Education and Research in Thrombotic Disease","id_on_source":"ThrombosisCan","tweeter_id":"2192982972","geo":{"lt":null,"ln":null},"followers":805},"tweet_id":"827905943723765765"},{"url":"http:\/\/twitter.com\/thrombosisday\/statuses\/828050912828604417","license":"gnip","rt":["Cihan_Ay_MD"],"citation_ids":[14268299],"posted_on":"2017-02-05T01:21:36+00:00","author":{"name":"World Thrombosis Day","url":"http:\/\/www.worldthrombosisday.org","image":"https:\/\/pbs.twimg.com\/profile_images\/816287382316183552\/KGRGMg3V_normal.jpg","description":"Global year-long movement to build awareness about #bloodclots. Join #WTDay17 movement on 13 October! https:\/\/t.co\/6cG9cwoa8M #KnowThrombosis #KeepLifeFlowing","id_on_source":"thrombosisday","tweeter_id":"2340601688","geo":{"lt":null,"ln":null},"followers":4974},"tweet_id":"828050912828604417"},{"url":"http:\/\/twitter.com\/GFHT_Hemostase\/statuses\/828176795723845636","license":"gnip","rt":["RPTHjournal"],"citation_ids":[14268299],"posted_on":"2017-02-05T09:41:49+00:00","author":{"name":"GFHT","url":"http:\/\/www.geht.org","image":"https:\/\/pbs.twimg.com\/profile_images\/713402108343623681\/UzVxEsM4_normal.jpg","description":"Groupe Fran\u00e7ais d'\u00e9tudes sur l'H\u00e9mostase et la Thrombose (anciennement GEHT), groupe d'\u00e9tude de la SFH. French Group of Haemostasis and Thrombosis","id_on_source":"GFHT_Hemostase","tweeter_id":"713400472749666304","geo":{"lt":48.85341,"ln":2.3488,"country":"FR"},"followers":158},"tweet_id":"828176795723845636"},{"url":"http:\/\/twitter.com\/tromboinfo\/statuses\/828187043465457664","license":"gnip","rt":["Cihan_Ay_MD"],"citation_ids":[14268299],"posted_on":"2017-02-05T10:22:32+00:00","author":{"name":"trombo.info","url":"http:\/\/www.trombo.info","image":"https:\/\/pbs.twimg.com\/profile_images\/654056378164752384\/K1AbCB0v_normal.jpg","description":"Tu web sobre enfermedad tromboemb\u00f3lica venosa #ETV #trombosis #emboliapulmonar #RIETEregistry  Your site about venous thromboembolism #bloodclot #DVT #PE #VTE","id_on_source":"tromboinfo","tweeter_id":"2280734660","geo":{"lt":null,"ln":null},"followers":508},"tweet_id":"828187043465457664"},{"url":"http:\/\/twitter.com\/isth\/statuses\/828242088517058563","license":"gnip","rt":["RPTHjournal"],"citation_ids":[14268299],"posted_on":"2017-02-05T14:01:16+00:00","author":{"name":"ISTH","url":"http:\/\/www.isth.org","image":"https:\/\/pbs.twimg.com\/profile_images\/786613687234748417\/a676FfU7_normal.jpg","description":"The International Society on Thrombosis and Haemostasis advances the understanding, prevention, diagnosis & treatment of thrombotic & bleeding disorders.","id_on_source":"isth","tweeter_id":"20373507","geo":{"lt":35.91014,"ln":-79.07529,"country":"US"},"followers":4295},"tweet_id":"828242088517058563"},{"url":"http:\/\/twitter.com\/MarcBlondon\/statuses\/828268882343374849","license":"gnip","citation_ids":[14268299],"posted_on":"2017-02-05T15:47:44+00:00","author":{"name":"Marc Blondon","image":"https:\/\/pbs.twimg.com\/profile_images\/734463834723880960\/ZLmMeRNX_normal.jpg","id_on_source":"MarcBlondon","tweeter_id":"734030822542594048","geo":{"lt":47.00016,"ln":8.01427,"country":"CH"},"followers":54},"tweet_id":"828268882343374849"},{"url":"http:\/\/twitter.com\/TH_Journal\/statuses\/828520766459277316","license":"gnip","citation_ids":[14268299],"posted_on":"2017-02-06T08:28:38+00:00","author":{"name":"TH","url":"http:\/\/www.thrombosis-haemostasis.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/812224056758046720\/FUt8i2Eu_normal.jpg","description":"Thrombosis and Haemostasis is a leading journal in basic, translational and clinical research on thrombosis, haemostasis and vascular biology.","id_on_source":"TH_Journal","tweeter_id":"751031084385697793","geo":{"lt":48.78232,"ln":9.17702,"country":"DE"},"followers":146},"tweet_id":"828520766459277316"},{"url":"http:\/\/twitter.com\/Cihan_Ay_MD\/statuses\/828523413299949568","license":"gnip","rt":["TH_Journal"],"citation_ids":[14268299],"posted_on":"2017-02-06T08:39:09+00:00","author":{"name":"Cihan Ay","image":"https:\/\/pbs.twimg.com\/profile_images\/827814018660388864\/YHatyhrv_normal.jpg","id_on_source":"Cihan_Ay_MD","tweeter_id":"277967241","geo":{"lt":48.2082,"ln":16.37169,"country":"AT"},"followers":153},"tweet_id":"828523413299949568"},{"url":"http:\/\/twitter.com\/tromboinfo\/statuses\/829344933362413568","license":"gnip","rt":["RPTHjournal"],"citation_ids":[14268299],"posted_on":"2017-02-08T15:03:35+00:00","author":{"name":"trombo.info","url":"http:\/\/www.trombo.info","image":"https:\/\/pbs.twimg.com\/profile_images\/654056378164752384\/K1AbCB0v_normal.jpg","description":"Tu web sobre enfermedad tromboemb\u00f3lica venosa #ETV #trombosis #emboliapulmonar #RIETEregistry  Your site about venous thromboembolism #bloodclot #DVT #PE #VTE","id_on_source":"tromboinfo","tweeter_id":"2280734660","geo":{"lt":null,"ln":null},"followers":508},"tweet_id":"829344933362413568"}],"facebook":[{"title":"Timeline Photos","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1722818404638243&id=1447144365538983","license":"public","citation_ids":[14268299],"posted_on":"2017-02-06T08:25:32+00:00","summary":"Venous thromboembolism (VTE) is a significant health problem in the general population but especially in cancer patients. \nIn their February issue Review article, Ay et al.  discuss the epidemiology and burden of the disease, the pathophysiology of cancer-","author":{"name":"Thrombosis and Haemostasis","url":"https:\/\/www.facebook.com\/1447144365538983","facebook_wall_name":"Thrombosis and Haemostasis","image":"https:\/\/graph.facebook.com\/1447144365538983\/picture","id_on_source":"1447144365538983"}}]}}